November 14, 2024
Boston, MA
Finnegan
Licensing Executives Society USA & Canada – Boston Chapter
Join a panel of experts to discuss business strategies for commercializing and licensing AI innovations, how to build an IP portfolio that supports those strategies, and key terms to address in licensing negotiations from both the licensor and licensee perspective. Panelists will share insights on different approaches to commercializing and licensing AI technology, including AI platforms for drug discovery, generative AI platforms, and consumer products that incorporate AI functionality.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.